A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells
Using a CRISPR-based large-scale screen, Gilad et al. identify the genes that show synthetic lethality with an SRC-3 inhibitor in breast cancer cells while contrasting this with the estrogen receptor degrader fulvestrant. This study provides insights into the development of therapeutic strategies fo...
Guardado en:
Autores principales: | Yosi Gilad, Yossi Eliaz, Yang Yu, Adam M. Dean, San Jung Han, Li Qin, Bert W. O’Malley, David M. Lonard |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6fce305479b5409cbdcf3ff5d35853b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Steroid receptor coactivator 3 (SRC-3/AIB1) is enriched and functional in mouse and human Tregs
por: Bryan C. Nikolai, et al.
Publicado: (2021) -
Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities
por: Kendall R. Sanson, et al.
Publicado: (2018) -
Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria
por: Chen Dong, et al.
Publicado: (2018) -
Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC
por: Deborah Y. Kwon, et al.
Publicado: (2017) -
Generating viable mice with heritable embryonically lethal mutations using the CRISPR-Cas9 system in two-cell embryos
por: Yi Wu, et al.
Publicado: (2019)